NCT01691885View on ClinicalTrials.gov

RELOVAIR® Lung Deflation Study

PHASE3CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

July 31, 2014

Study Completion Date

August 31, 2014

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

Fluticasone Furoate

100mcg Once daily

DRUG

Vilanterol

25mcg Once daily

Trial Locations (1)

E2 9JX

GSK Investigational Site, London

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01691885 - RELOVAIR® Lung Deflation Study | Biotech Hunter | Biotech Hunter